Dynamic Brain Imaging of Speech in Primary Progressive Aphasia
原发性进行性失语症言语的动态脑成像
基本信息
- 批准号:9766414
- 负责人:
- 金额:$ 56.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAlzheimer’s disease biomarkerAmyloidAnteriorAtrophicBehavioralBindingBiological AssayBiological MarkersBrainBrain imagingClassificationClinicalDataDevelopmentDifferential DiagnosisDiseaseDorsalFeedbackFrequenciesFrontotemporal Lobar DegenerationsGoalsGrantImageInferiorKnowledgeLanguageLanguage DisordersLanguage PathologyLanguage TestsLeftMagnetic Resonance ImagingMagnetoencephalographyMeasuresMethodologyMethodsMolecularMotorNeuronal DysfunctionNeurosciencesParietalPathologicPathologyPatientsPatternPerformancePositron-Emission TomographyPreparationPrimary Progressive AphasiaProductionReproductionRestSemanticsShort-Term MemorySpeechSyndromeTimeTracerVariantcerebral atrophyclinical Diagnosisclinical heterogeneitycognitive testingdiagnostic biomarkerimaging biomarkerimaging modalityimprovedindividual patientmotor controlnervous system disordernetwork dysfunctionphonologyrehearsalrelating to nervous systemresponsetemporal measurement
项目摘要
Project Summary
Primary progressive aphasia (PPA) is a clinical syndrome characterized by isolated, progressive loss of
speech and language abilities. PPA occurs when pathological and molecular changes of frontotemporal lobar
degeneration (FTLD) or Alzheimer's disease (AD) selectively damage language-specific networks of the brain.
There is considerable variability in the distribution of brain atrophy in PPA, and patterns of language deficits
vary accordingly. In particular, three clinical variants of PPA have been identified: i) logopenic variant (lvPPA)
associated with loss of phonological abilities, left temporal-parietal atrophy and most often AD pathology; ii)
nonfluent/agrammatic variant (nfvPPA) with motor speech and grammar deficits, left inferior frontal damage
and often FTLD pathology; and iii) semantic variant (svPPA), with loss of conceptual knowledge, anterior
temporal damage and also most often with FTLD-type pathology. This classification has greatly improved PPA
diagnosis but clinical heterogeneity remains an issue, even within each variant, as individual patients differ in
terms of their specific patterns of atrophy, language deficits and pathology. In the early stages of the disease,
differential diagnosis between lvPPA and nfvPPA is particularly challenging as speech errors can occur in both
conditions and atrophy might initially be subtle.
To better distinguish between PPA variants, in this grant, we propose to examine neural oscillations in
PPA using high temporal resolution brain imaging with magnetoencephalography (MEGI). We will examine
regional neural oscillatory activity associated with speaking with a precision unmatched by any other imaging
modality. MEGI data will be examined in conjunction with detailed cognitive and language testing, MRI and
molecular PET imaging with the amyloid binding tracer PIB biomarker for AD that will be available in all our
subjects. The specific aims are:
1. To identify differential patterns of frequency-specific resting-state oscillatory activity and functional
connectivity in early stages of PPA variants
2. To examine cortical oscillatory network activity during speech feedback processing in PPA variants
3. To examine cortical oscillatory network activity during sequential speech production in PPA variants
Overall, our findings will enable us to identify some of the earliest functional manifestations of brain
network dysfunction in PPA, leading to the development of useful biomarkers to detect and longitudinally
assess the progressive speech decline in PPA.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARIA LUISA GORNO TEMPINI其他文献
MARIA LUISA GORNO TEMPINI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARIA LUISA GORNO TEMPINI', 18)}}的其他基金
An automated machine learning approach to language changes in Alzheimer’s disease and frontotemporal dementia across Latino and English-speaking populations
一种针对拉丁裔和英语人群中阿尔茨海默病和额颞叶痴呆的语言变化的自动化机器学习方法
- 批准号:
10662053 - 财政年份:2023
- 资助金额:
$ 56.23万 - 项目类别:
Chinese Language Assessment in Primary Progressive Aphasia
原发性进行性失语症的汉语评估
- 批准号:
10219014 - 财政年份:2021
- 资助金额:
$ 56.23万 - 项目类别:
Chinese Language Assessment in Primary Progressive Aphasia
原发性进行性失语症的汉语评估
- 批准号:
10437736 - 财政年份:2021
- 资助金额:
$ 56.23万 - 项目类别:
Dynamic Brain Imaging of Speech in Primary Progressive Aphasia
原发性进行性失语症言语的动态脑成像
- 批准号:
10237347 - 财政年份:2017
- 资助金额:
$ 56.23万 - 项目类别:
Dynamic Brain Imaging of Speech in Primary Progressive Aphasia
原发性进行性失语症言语的动态脑成像
- 批准号:
10740640 - 财政年份:2017
- 资助金额:
$ 56.23万 - 项目类别:
Training program in the neurology of language and neurodegenerative aphasias
语言神经病学和神经退行性失语症培训计划
- 批准号:
10216095 - 财政年份:2016
- 资助金额:
$ 56.23万 - 项目类别:
Training program in the neurology of language and neurodegenerative aphasias
语言神经病学和神经退行性失语症培训计划
- 批准号:
9307799 - 财政年份:2016
- 资助金额:
$ 56.23万 - 项目类别:
Training program in the neurology of language and neurodegenerative aphasias
语言神经病学和神经退行性失语症培训计划
- 批准号:
10677639 - 财政年份:2016
- 资助金额:
$ 56.23万 - 项目类别:
Training program in the neurology of language and neurodegenerative aphasias
语言神经病学和神经退行性失语症培训计划
- 批准号:
10449271 - 财政年份:2016
- 资助金额:
$ 56.23万 - 项目类别:
Connectomic imaging in familial and sporadic frontotemporal degeneration
家族性和散发性额颞叶变性的连接组学成像
- 批准号:
9110441 - 财政年份:2016
- 资助金额:
$ 56.23万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 56.23万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 56.23万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 56.23万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 56.23万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 56.23万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 56.23万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 56.23万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 56.23万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 56.23万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 56.23万 - 项目类别: